Gross DW, Hippocampal subfield measurement and ILAE hippocampal sclerosis subtype classification with in vivo 4.7tesla MRI, Epilepsy Research (2020), Highlights  In vivo MRI reveals variability of HS subtypes along the hippocampal long axis  Individual patients demonstrate dramatically different HS subtype atrophy patterns  Subregional atrophy is detected along the long axis in patients with normal volumetry
Introduction
While hippocampal sclerosis (HS) is the most common lesion associated with intractable epilepsy , several studies have demonstrated considerable heterogeneity regarding pathological involvement of different hippocampal subfields in this condition (Blumcke et al., 2007; Bruton, 1988; Davies et al., 1996; De Lanerolle et al., 2003; Sagar and Oxbury, 1987; Thom et al., 2010; Van Paesschen et al., 1997) . Surgical specimens from J o u r n a l P r e -p r o o f individual patients can demonstrate the classical pattern of neuron loss in both CA1 and CA4 (ILAE Type 1 HS), CA1 predominant disease (ILAE Type 2 HS), or end folium (CA4) sclerosis (ILAE Type 3 HS) (Blumcke et al., 2013) . Patients with medically intractable temporal lobe epilepsy (TLE) and HS can have an excellent surgical outcome. However, long term follow up demonstrates that only around 50% of patients remain seizure-free 10-years postoperatively (de Tisi et al., 2011) . Classification of the HS subtypes described above (Blumcke et al., 2013) based on subfield analysis of postoperative pathology has been shown to provide important prognostic information regarding expected surgical outcomes, with ILAE Type 1 HS having the best prognosis (Blumcke et al., 2007; Thom et al., 2010) . However, a reliable method to determine HS subtype preoperatively has not yet been established.
Along with heterogeneity of subfield involvement between subjects with HS, variability of pathological changes in subfields has also been demonstrated along the long axis of the hippocampus for individual subjects (Thom et al., 2012) . In addition, autopsy studies have demonstrated subtle HS contralateral to the seizure focus in some patients with TLE (Babb, 1991; Margerison and Corsellis, 1966; Thom et al., 2012) . The portion of the hippocampus posterior to the resection (the "posterior remnant") and the unresected contralateral hippocampus, neither of which are possible to study with surgical pathology, may both be important in predicting postoperative seizure recurrences.
Magnetic Resonance Imaging (MRI) was the first technology to demonstrate HS noninvasively (Berkovic et al., 1991; Jackson et al., 1990; Jackson et al., 1993; Kuzniecky et al., 1987) , and MRI evidence of HS is associated with better surgical outcomes (Berkovic et al., 1995) . With increasing MRI magnetic field strength, the spatial resolution of MRI continues to improve, to the point where it has now become feasible to study individual hippocampal J o u r n a l P r e -p r o o f subregions (Mueller et al., 2007; Pan et al., 1995) . CA1 and CA4 subfields can now be measured in patients with HS (Mueller et al., 2009) , which provides the potential opportunity to more accurately predict surgical outcome with HS subtype diagnosis prior to surgery (Eriksson et al., 2008) .
However, a significant challenge is the fact that hippocampal subfields are defined according to cytoarchitectonic features which are not discernible with MRI (van Strien et al., 2012) . While existing protocols have been based on a standard anatomical reference (Duvernoy, 2005) , the relationships between in vivo segmentation rules and histology have not been analyzed. As a direct result, a large number of methods using different rules have been described for hippocampal subfield segmentation (Yushkevich et al., 2015) . The development of histologically validated in vivo MRI segmentation methods holds potential to address these current limitations.
We have recently developed a method for hippocampal body segmentation based on histology and ex vivo MRI of the human hippocampus (Steve et al., 2017) . However, ex vivo MRI of cadaveric hippocampi provides much higher spatial resolution (voxel size 0.2 x 0.2 x 0.5 mm 3 ) than can currently be achieved in vivo. This greater spatial resolution provides superior visualization of anatomical landmarks than is possible with in vivo MRI. Therefore, whether our segmentation method can be implemented reliably with in vivo MRI has not been determined.
Furthermore, whether reliability of this method is affected by the presence of hippocampal pathology remains unknown.
In the present study, we aimed to: 1) Determine the intra-and inter-rater reliability for in vivo application of our hippocampal segmentation protocol -in control subjects and TLE J o u r n a l P r e -p r o o f patients with unilateral HS; and 2) Analyze hippocampal subfield areas and volumes to determine possible ILAE HS subtype atrophy patterns with in vivo MRI.
Materials and Methods
Ten healthy subjects (age 21-41, five males) served as controls and were compared with eleven patients with TLE (age 22-58, nine males). The work described in this paper was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki).
Research ethics approval was obtained from the University of Alberta Research Ethics Board and all subjects gave written informed consent. Each of the patients had unilateral (six right) HS detected with 1.5T clinical MRI scans (consisting of both increased T2 signal and reduced volume in the ipsilateral hippocampus). High resolution MR-Imaging was performed on a 4.7T MRI system (Varian, Palo Alto, CA). In all controls and in nine out of eleven patients with HS, a T2-weighted (inverted contrast) fast-spin-echo technique was used to acquire 90 contiguous 1.0-mm-thick coronal slices, perpendicular to the anterior commissure -posterior commissure (AC-PC) line, including the entire hippocampal formation [echo time = 39 ms, repetition time = 11,000 ms, FOV 20x20 cm, in-plane matrix 384x296] yielding a native resolution of 0.52 x 0.68 x 1.0 mm 3 in 13.5 minutes of total scan time. Images were then interpolated in-plane by a factor of 2, yielding a final resolution of 0.26 x 0.34 x 1 mm 3 as previously described (Malykhin et al., 2010) . While our final protocol was being optimized, two HS subjects were scanned with slightly different protocols which resulted in different spatial resolutions for these patients as follows: a) subject 7 -0.25 x 0.25 x 2 mm 3 ; and b) subject 8 -0.2 x 0.2 x 1.5 mm 3 . We chose to include these subjects in our analyses to increase our sample size, as their data were qualitatively and quantitatively similar to those scanned with the final protocol. The landmarks used for segmentation of the hippocampal body are shown in Figure 1 . The presence of uncal tissue was used to define the most posterior slice of the hippocampal head (1, Figure 1A ) (Malykhin et al., 2007) . Hippocampal body segmentation began on the most anterior slice where uncal tissue was absent (2, Figure 1B ) (Malykhin et al., 2007) . In all subjects, subfield segmentation was restricted to the hippocampal body and the hippocampal head and tail were excluded from the analysis. In all controls and in ten out of eleven patients with HS, the boundary between the hippocampal body and the hippocampal tail was determined by measuring 15-mm posteriorly from the head-body junction ( Figure 1C ). This rule was used to ensure that body segmentation occurred on a standard number of slices in all subjects, with the aim of producing comparable volume measurements across subjects In one subject with HS (with a slice thickness of 2 mm), the body-tail junction was located 16 mm (8 slices) posterior to the head-body junction (subject 7).
Segmentation of hippocampal subfields using in vivo MRI

-Hippocampal subfield segmentation
In vivo subfield segmentation of the hippocampal body is shown in Figure 2 . Manual hippocampal subfield segmentation was performed using the ITK-SNAP software package (Yushkevich et al., 2006) . Segmentation was performed in the coronal plane (perpendicular to the AC-PC line) on each of the contiguous slices along the hippocampal body (Figure 2A ), while the sagittal and axial planes were systematically checked to confirm anatomical landmarks.
Figure 1 -Delineation of the hippocampal body from the head and tail:
The head-body junction was defined by the presence of the uncus in the hippocampal head (1, panel A) and the disappearance of the uncus (2, panel B) in the hippocampal body. The bodytail junction was located 15 mm posterior to the head (3) -body (4) junction (panel C). Subfield segmentation was performed in the hippocampal body (turquoise), while the hippocampal head (purple) and tail (teal) were excluded.
Segmentation was based on an MRI-visible anatomical landmark: the stratum lacunosummoleculare (SLM). The beginning (1, Figure 2B ) of the SLM was identified at the superficial hippocampal sulcus (Steve et al., 2017) . The termination of the SLM (2, Figure 2C ) was identified visually based on signal intensity differences from hippocampal grey matter. A curvilinear line (blue, Figure 2D ) was then drawn at the tissue interface between the SLM and the cornu ammonis. The length of this line was measured using the curvilinear measurement tool in ImageJ (Schneider et al., 2012) to determine the total SLM length. Hippocampal subfield transitions ( Figure 2E ) were then determined as a proportion of the total SLM length (Steve et al., 2017) : Subiculum/CA1 (26% of SLM); CA1/CA2 (78% of SLM); and CA2/CA3 (98% of SLM). At each transition, a line was drawn perpendicular to the SLM to define the subfield boundaries ( Figure 2E ). Subfields were then delineated using tissue contrast between grey and white matter. The mesial boundary of the subiculum was defined by a loss of grey matter signal intensity at the superomesial aspect of the parahippocampal gyrus ( Figure 2F ).
The cortical mantle was then followed from the subiculum laterally over the cornu ammonis and DG, with the alveus and SLM being excluded from subfield measurements. The segmentation 
Figure 3 -Hippocampal subfield measurements:
Left panels: High resolution unlabelled in vivo MR Images of the hippocampus are shown bilaterally from a normal control (top row), a subject with right hippocampal sclerosis (HS, middle row), and a subject with left HS (bottom row).
Right panels:
Hippocampal subfields [(Subiculum, green); (CA1, red); (CA2, yellow); (CA3/CA4/DG, magenta)] were delineated on the same slices as shown on the left. The subject with Right HS demonstrated atrophy of all subfields. In contrast, the subject with Left HS revealed reduced area primarily at CA1.
Evaluation of Intra-and Inter-rater Reliability
Reliability of the segmentation protocol was evaluated in five controls (10 hippocampi) and five patients with HS (10 hippocampi). Each hippocampus was segmented twice by a single investigator (TAS) at an interval of 1 week for evaluation of intra-rater reliability. The segmentations were then repeated by a second investigator (JG) for evaluation of inter-rater J o u r n a l P r e -p r o o f reliability. Agreement was evaluated by measuring the amount of spatial overlap between the two segmentations using the Dice Similarity Coefficients (DSCs) (Dice, 1945) , which were calculated as follows. 
Comparison of hippocampal subfield volumes in controls and patients
Characterizing HS Subtype atrophy patterns along hippocampal long axis
2.4.1 Methodology of HS Subtype slice classification CA1 and CA3/CA4/DG subfield areas at each of the contiguous slices along the hippocampal long axis were used to determine HS subtype atrophy patterns bilaterally ( Figure 4 ). In all controls and in nine out of eleven patients with HS (in whom the spatial resolution was 0.26 x 0.34 x 1 mm 3 ), subfield area measurements were obtained directly by measuring the volume of each 1 mm thick slice. For subject 7 (spatial resolution 0.25 x 0.25 x 2 mm 3 ) and subject 8 (resolution 0.2 x 0.2 x 1.5 mm 3 ), the volume of each slice was divided by a factor of 2 and 1.5 respectively to correct for the differences in slice thickness between subjects.
Control subfield areas were measured from 10 subjects bilaterally (20 hippocampi) at 15 slices each, for a total of 300 control slices. The lower limit of normal was defined using the 10 th percentile from the control group. An individual slice area measurement was defined as normal if it was above the lower limit of normal and abnormal if it fell below the lower limit of normal.
J o u r n a l P r e -p r o o f
In subjects with HS, each slice was then classified as an HS subtype pattern based on evaluation of subfield areas: No HS (CA1 and CA3/CA4/DG normal); Type 1 HS (CA1 and CA3/CA4/DG abnormal); Type 2 HS (CA1 abnormal but CA3/CA4/DG normal); Type 3 HS (CA1 normal but CA3/CA4/DG abnormal) (Blumcke et al., 2013) .
Figure 4 -HS Subtype atrophy patterns along the hippocampal long axis:
A-D) Subfield areas (mm 2 ) at each of 15 slices from a single subject with right HS (Subject 2) are shown for CA1 (A & B) and CA3/CA4/DG (C&D) bilaterally.
E) The presence or absence of subfield atrophy on MRI at CA1 versus CA3/CA4/DG was used to determine the ILAE HS subtype atrophy pattern (Panel E) at each of 15 slices along the longitudinal axis of the hippocampus for each subject bilaterally.
F) Volume rendering depicting HS Subtypes in the contralateral (left) and ipsilateral (right) hippocampi is consistent with Type 3 HS in the anterior ipsilateral body and Type 1 HS in the posterior body. While the majority of the contralateral hippocampus is normal, slices consistent with Type 2 and Type 3 HS are also observed.
Results
J o u r n a l P r e -p r o o f
General Observations
Clinical information for subjects with TLE is provided in Table 1 . The hippocampal internal architecture, including the SLM, was clearly visualized in controls and contralateral hippocampi from subjects with TLE ( Figure 3) . While in TLE patients the SLM of the ipsilateral hippocampus was less clearly visualized in comparison to controls (Figure 3) , the internal architecture was still adequate to perform subfield segmentation in all subjects.
Reliability
Controls
Intra-and inter-rater reliability data for the segmentation protocol in healthy controls are shown in Table 2 . Reliability of CA1 measurements in control subjects were as follows: intra-rater (DSC = 0.87 ± 0.03); inter-rater (DSC = 0.78 ± 0.06). Reliability of CA3/CA4/DG segmentations in control subjects were as follows: intra-rater (DSC = 0.90 ± 0.04); inter-rater (DSC = 0.84 ± 0.04).
Hippocampal sclerosis
Intra-and inter-rater reliability data for the segmentation protocol in subjects with HS are shown in Table 3 . Reliability of CA1 segmentation in subjects with HS was as follows: intra-rater (DSC = 0.82 ± 0.05); inter-rater (DSC = 0.77 ± 0.04). Reliability of CA3/CA4/DG measurements in subjects with HS were as follows: intra-rater (DSC = 0.86 ± 0.04); inter-rater (DSC = 0.81 ± 0.03).
Subfield-specific volume loss in patients with hippocampal sclerosis
J o u r n a l P r e -p r o o f CA1 and CA3/CA4/DG hippocampal subfield volumes from controls and patients with HS are shown in Figure 5 (A&B). A single subject accounted for both abnormal CA1 volume measurements in the control group.
Figure 5 -Subfield-specific volume loss in subjects with hippocampal sclerosis:
Volume measurements for CA1 (A) and CA3/CA4/DG (B) subfields were used to define HS subtype atrophy patterns in the contralateral (C) and ipsilateral (D) hippocampi for 11 subjects with unilateral hippocampal sclerosis (HS). Volumetric analysis of the ipsilateral hippocampus (D) revealed six patients with type 1 HS, two patients with type 2 HS, and three patients with type 3 HS; while five patients had evidence of type 3 HS in the contralateral hippocampus (C).
The same subject was also found to have one abnormal CA3/CA4/DG volume measurement, whereas a second individual accounted for the other abnormal result at this subregion.
Individual patients demonstrated different patterns of subfield-specific volume loss in the J o u r n a l P r e -p r o o f ipsilateral hippocampus ( Figure 5D ). Based on volumetric analysis, six subjects (subjects 1, 3, 4, 6, 7 and 8) demonstrated findings consistent with ILAE type 1 HS (involvement of both CA1 and CA4). Subjects 2, 9 and 10 demonstrated findings consistent with ILAE type 3 HS (involvement of CA4). Subjects 5 and 11 demonstrated findings consistent with ILAE type 2 HS (involvement of CA1).
Volume loss was also subject-specific in the contralateral hippocampus ( Figure 5C ).
Five subjects (subjects 1, 2, 4, 8 and 9) demonstrated atrophy of the CA3/CA4/DG subfields, consistent with an ILAE type 3 HS pattern contralateral to the seizure focus. Six subjects (subjects 3, 5, 6, 7, 10 and 11) did not have appreciable abnormalities of the contralateral hippocampus with volumetric analysis.
-Assessment of HS subtypes along the hippocampal long axis
In healthy control subjects, 50/300 (17%) of control slices met criteria for one of the HS subtypes. The hippocampi with abnormal volume measurements at either CA1 or CA3/CA4/DG (see section 3.3 above) accounted for 29/50 (58%) of these abnormal slices, demonstrating some clustering of abnormal area measurements in subjects with abnormal volumetry results.
Bilateral hippocampal volume renderings showing HS subtype atrophy patterns throughout the long axis, for each subject with HS, are shown in Figure 6 . Ipsilateral to the seizure focus, only one patient (subject 7) was found to have a uniform HS subtype (type 1 HS) at all slices throughout the hippocampal body. Three additional patients (subjects 4, 9, and 11) had >75% of slices matching the overall volumetric HS classification for the ipsilateral hippocampus, which is consistent with a relatively homogenous pattern of disease in these patients. In contrast, the remaining seven patients (subjects 1, 2, 3, 5, 6, 8, and 10) demonstrated J o u r n a l P r e -p r o o f <75% of slices concordant with subfield volumetry results, suggesting significant variability of HS subtypes along the ipsilateral hippocampal long axis in these subjects.
In the contralateral hippocampus, subfield area analysis detected abnormalities at a higher proportion of slices (34%) than expected from the control population (17%, Fisher's exact test p<0.0001). While contralateral hippocampal volumes were in the normal range for six patients (subjects 3, 5, 6, 7, 10 and 11) only three of these (subjects 5, 6 and 11) had uniformly normal areas on all slices of the hippocampal body. The remaining eight patients (subjects 1, 2, 3, 4, 7, 8, 9, and 10) all demonstrated several slices of HS in the contralateral hippocampus on subfield area analysis. In contrast to the ipsilateral hippocampi where Type 1 HS was the most common pattern demonstrated, type 2 and type 3 HS atrophy patterns were seen more commonly contralateral to the seizure focus.
-Histopathologic Classification of HS Subtypes
Although detailed pathological correlation was not a primary aim of the present study, clinical neuropathology diagnoses were available for eight HS subjects who underwent surgery (Table   1 ). While en bloc resections were not performed, a small biopsy specimen suitable for pathological analysis was obtained from the posterior head / anterior body intra-operatively and evaluated for pathological HS subtype based on ILAE criteria (Blumcke et al., 2013) . Subjects 1-7 were found to have type 1 HS on pathology, while subject 8 was diagnosed with type 2 HS following pathological analysis. Thus, hippocampal subfield volumetry results for the body were Volume renderings are shown from eleven subjects with unilateral hippocampal sclerosis (HS). HS subtype classifications based on hippocampal subfield volume measurements (derived from Figure 5 ) are listed below each hippocampus. Individual slices were colour-coded according to HS subtype (legend) using the methodology described in Figure 4 . Only four subjects (4, 7, 9, and 11) had homogenous HS subtype patterns throughout the ipsilateral hippocampus. Furthermore, only three subjects (5, 6, and 11) demonstrated a completely normal hippocampus contralateral to the seizure focus.
Discussion
In the present study, we used in vivo 4.7T MRI to characterize HS subtype atrophy patterns in eleven patients with TLE. Our histology-derived method (Steve et al., 2017) demonstrated excellent intra-and inter-rater reliability in controls and subjects with HS, which was comparable to previous protocols (Das et al., 2011; Goubran et al., 2016; Henry et al., 2011; Mueller et al., 2009; Mueller et al., 2012) . In the ipsilateral hippocampus, volumetry revealed six subjects with ILAE type 1 HS and five subjects with atypical HS (two ILAE type 2 HS & three ILAE type 3 HS). Although pathological correlation was not the primary aim of our study as complete en bloc specimens were not available for histological analysis, volumetry results were concordant with clinical neuropathological findings in five out of eight subjects (63%).
In a subset (36%) of TLE patients subfield area analyses of the ipsilateral hippocampus revealed homogenous HS patterns (>75% of slices concordant with volumetry findings) along the long axis of the hippocampus. However, the majority (64%) of TLE patients demonstrated remarkable variability (<75% of slices concordant with volumetry) of HS patterns along the hippocampal long axis. The variability of HS subtypes along the long axis demonstrated in our analyses adds to an existing literature suggesting that in order to adequately define HS in patients with TLE, the entire long axis must be examined. Previous MRI studies have shown that sclerosis can be seen at specific locations along the hippocampal long axis, while some segments of the hippocampus can appear normal on MRI (Bronen et al., 1995) . Furthermore, recent autopsy studies have demonstrated significant heterogeneity of HS subtypes along the hippocampal long axis (Thom et al., 2012) .
Contralateral to the seizure focus, only three subjects demonstrated a completely normal hippocampus -which is consistent with previous autopsy studies demonstrating bilateral J o u r n a l P r e -p r o o f neuronal loss in TLE (Babb, 1991) . Eight of eleven subjects demonstrated at least one slice of Type 3 HS in the contralateral hippocampus on subfield area analysis, which may represent 'end folium sclerosis' as described in previous autopsy series (Margerison and Corsellis, 1966) . These subregional abnormalities were not detected with volumetric analysis in three of these eight subjects, each of whom demonstrated normal contralateral hippocampal subfield volumes. In these patients (subjects 3, 7 and 10), abnormalities at  3 slices were not reflected by volumetry due to the normal measurements throughout the majority of the hippocampus (Figure 6 ). This finding further emphasizes the importance of characterizing the entire hippocampus along the long axis in patients with TLE. However, the clinical significance of these findings remains uncertain given that two of these patients has had an excellent surgical outcome (Table 1) .
While individual surgical pathology series have suggested prognostic significance of HS subtype diagnoses (Blumcke et al., 2007) , surgical outcomes for HS subtypes have not been consistent across studies (Thom et al., 2010) . For example, in one study (Blumcke et al., 2007) , Type 2 HS patients had a similar likelihood (67%) of seizure freedom compared with Type 1 HS patients (72%). In another study, however, Type 2 HS patients had a much poorer prognosis (33% seizure-free) than those with Type 1 HS (69% seizure-free) (Thom et al., 2010) . Similarly, Type 3 HS was shown to be associated with a very low (28%) chance of seizure freedom (Blumcke et al., 2007) , while another study found that Type 3 HS was associated with an excellent prognosis (100% seizure free) (Thom et al., 2010) . There are several potential reasons for the discordant results in these previous studies including different extent of surgical resections, variable presence of bilateral hippocampal pathology, and disparate length of postsurgical followup across studies. Variability of HS subtypes along the hippocampal long axis, as described above (Thom et al., 2012) and demonstrated in the present study, represents another J o u r n a l P r e -p r o o f potential reason for the discordant surgical outcomes across studies. Biopsies of the hippocampus obtained during epilepsy surgery often represent only a small portion of the entire structure -and therefore cannot accurately reflect subtype pathology across the entire long axis (Thom et al., 2012) . In vivo MRI-based methods hold promise to address this current limitation by allowing determination of HS subtypes along the entire hippocampal longitudinal axis, both ipsilateral and contralateral to known HS, which may eventually allow more accurate prediction of surgical outcomes.
The remarkable inter-subject variability demonstrated in TLE in the present study strongly suggests that HS subtypes should be characterized bilaterally along the entire hippocampal long axis and assessed independently in individual patients with TLE. While neuroimaging methods which pool patients together will detect group differences , such techniques would be expected to miss important differences between patients.
Limitations
In the present study, we used quantitative rules developed from histology samples of healthy controls (Steve et al., 2017) to distinguish the in vivo locations of hippocampal subfields. It is possible that HS results in altered boundaries of hippocampal subfields in subjects with TLE (van Strien et al., 2012) , which could potentially affect our findings. However, at present there are insufficient data available in the literature from which to develop a segmentation protocol specifically for subjects with HS. Similarly, it remains unknown whether our boundary definitions are valid across the spectrum of hippocampal shape variability in healthy controls or in subjects with hippocampal malformations. However, we believe that our method represents a reasonable approximation since more comprehensive data regarding the precise locations of hippocampal subfields are lacking in the scientific literature.
J o u r n a l P r e -p r o o f
The imaging plane used for subfield segmentation represents another potential limitation of our study. Our boundary definitions were derived using ex vivo imaging and histological data acquired perpendicular to the hippocampal long axis (Steve et al., 2017) , while in the present study we have performed in vivo segmentation perpendicular to the AC-PC line. It is possible that this change in plane of imaging may have resulted in different subfield area and volume measurements for both control and TLE subjects in our study. However, we believe that our approach is reasonable since some existing in vivo protocols also perform segmentation perpendicular to the AC-PC line (Malykhin et al., 2010) . Furthermore, we are not aware of evidence in the literature demonstrating that segmentation perpendicular to the hippocampal long axis is superior to that performed perpendicular to the AC-PC line.
In the present study, we were unable to correct for total intracranial volume (ICV) due to an error resulting in incomplete whole-brain coverage of the volumetric T1 scans acquired in the control group. Furthermore, as pathological specimens were available only from the head / 
Conclusions
In the present study, we describe a novel method to characterize HS subtypes using in vivo MRI with excellent reliability. Volume measurements of the hippocampal body demonstrated evidence of HS in the ipsilateral hippocampus of all patients (six patients with type 1 HS, two patients with type 2 HS, and three patients with type 3 HS). However, heterogeneity of HS subtype observed in slices for the majority of ipsilateral hippocampi in association with the demonstration of abnormalities of the contralateral hippocampus at the slice level that were often not observed with hippocampal body volume measurements highlight the importance of studying hippocampal subfield pathology along the entire length of the hippocampus bilaterally in TLE. Further studies are required evaluate HS subtype atrophy patterns in the hippocampal head and tail, which were not evaluated in the present study. 
Table 2: Intra-and inter-rater reliability in controls
Dice similarity coefficient (DSC) data are shown for CA1, CA2, CA3/CA4/DG, and subiculum segmentations in healthy controls. Intra-rater reliability was superior to inter-rater reliability for each subfield. Reliability of CA1 measurements in control subjects were as follows: intra-rater (DSC = 0.87 ± 0.03); inter-rater (DSC = 0.78 ± 0.06). Reliability of CA3/CA4/DG in control subjects were as follows: intra-rater (DSC = 0.90 ± 0.04); inter-rater (DSC = 0.84 ± 0.04). 
J o u r n a l P r e -p r o o f
Table 3: Intra-and inter-rater reliability in hippocampal sclerosis
Dice similarity coefficient (DSC) data are shown for CA1, CA2, CA3/CA4/DG, and subiculum segmentations in subjects with hippocampal sclerosis (HS). Reliability of CA1 segmentation in subjects with HS was as follows: intra-rater (DSC = 0.82 ± 0.05); inter-rater (DSC = 0.77 ± 0.04). Reliability of CA3/CA4/DG measurements in subjects with HS were as follows: intrarater (DSC = 0.86 ± 0.04); inter-rater (DSC = 0.81 ± 0.03).
